Top Medical Stocks To Invest In Right Now

tags:ECL,CLSD,BDX,wh,TRIB,

If you find yourself with $1,000 all of a sudden -- or perhaps through slow consistent saving -- you might be wondering: What's next? Maybe ideas of a beach vacation are floating through your head, or maybe you're thinking about buying yourself a big-ticket gadget like a new computer or TV.

You can certainly spend your money on those things if you want, but here are 10 smart things you could do with that $1,000 right now to improve your financial well-being.

Image source: Getty Images.

1. Pay off your debts

If you're carrying any high-interest debt like a balance on your credit card, medical bills, or a personal line of credit, you should absolutely be paying it off as quickly as possible. $1,000 can go a long way toward clearing your debt, especially if you're only making minimum monthly payments.

When you pay off high-interest debt, you're effectively getting a guaranteed return on investment for your $1,000. So, if you have $1,000 in credit card debt accruing interest at a 20% annual rate, you'll save $200 per year in interest expenses you would have paid if you didn't pay down that debt.

Top Medical Stocks To Invest In Right Now: Ecolab Inc.(ECL)

Advisors' Opinion:

• [By Ethan Ryder]

  Ecolab Inc. (NYSE:ECL) – Jefferies Financial Group dropped their Q4 2018 EPS estimates for Ecolab in a report released on Tuesday, July 31st. Jefferies Financial Group analyst L. Alexander now anticipates that the basic materials company will post earnings per share of $1.73 for the quarter, down from their prior forecast of $1.74.

• [By Neha Chamaria]

  Using the above method, I believe the following five stocks are some of the best Dividend Aristocrats to consider today.

  Dividend Aristocrat Payout Ratio (Last 12 Months) 5-Year Dividend CAGR*  10-Year Dividend CAGR* Ecolab (NYSE:ECL) 30.2% 12.9% 12.3% W.W. Grainger (NYSE:GWW) 45.7% 10.6% 14.2% Cintas Corporation (NASDAQ:CTAS) 23.7% 19.8% 13.1% Roper Technologies (NYSE:ROP) 14.6% 20.4% 18.5% A. O. Smith (NYSE:AOS) 33.6% 25.5% (2.2%)

  *Compound annual growth rate. Data source: S&P Global Market Intelligence. Table by author.

• [By Scott Levine]

  Here are three starkly different opportunities -- Aqua America (NYSE:WTR), Franco-Nevada Corp. (NYSE:FNV), and Ecolab (NYSE:ECL) -- that could help investors avoid tossing and turning all night.

• [By ]

  3. Ecolab (NYSE: ECL)
  This water, hygiene, and energy services company is being heavily bought by Bill Gates. Mr. Gates has purchased around a million shares across several transactions in the last 30 days. His purchase price was between $134.00 and $137.00 per share.

• [By Joseph Griffin]

  Voya Investment Management LLC trimmed its position in shares of Ecolab Inc. (NYSE:ECL) by 1.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 92,817 shares of the basic materials company’s stock after selling 1,735 shares during the quarter. Voya Investment Management LLC’s holdings in Ecolab were worth $13,025,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top Medical Stocks To Invest In Right Now: Clearside BioMedical, Inc. (CLSD)

Advisors' Opinion:

• [By Chris Lange]

  Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on Thursday after the company released data from its midstage clinical trial for diabetic macular edema (DME). Specifically, this data came from the Phase 2 clinical trial (TYBEE) evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept).

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial. CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment. Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores. Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday. Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance. Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design. Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter. Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering. Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million. Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday. Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2
• [By Ethan Ryder]

  Shares of Clearside Biomedical Inc (NASDAQ:CLSD) have earned a consensus recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $22.40.

• [By Keith Noonan]

  Clearside Biomedical, Inc. Stock (NASDAQ:CLSD) stock rose 66.1% in March, according to data provided by S&P Global Market Intelligence.

• [By Lisa Levin]

  Clearside Biomedical, Inc. (NASDAQ: CLSD) was down, falling around 26 percent to $10.775. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.

Top Medical Stocks To Invest In Right Now: Becton, Dickinson and Company(BDX)

Advisors' Opinion:

• [By Ethan Ryder]

  Shares of Becton Dickinson and Co (NYSE:BDX) have earned a consensus recommendation of “Buy” from the eighteen research firms that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $239.67.

• [By Logan Wallace]

  Evergreen Capital Management LLC grew its holdings in shares of Becton Dickinson (NYSE:BDX) by 12.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 15,558 shares of the medical instruments supplier’s stock after acquiring an additional 1,768 shares during the quarter. Evergreen Capital Management LLC’s holdings in Becton Dickinson were worth $3,371,000 as of its most recent SEC filing.

• [By Keith Speights]

  Dividend Yield

  Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88% AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97% Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29% DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77% Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57% Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14% Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22% Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61% Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82% Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64% Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

  Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

Top Medical Stocks To Invest In Right Now: Smith(wh)

Advisors' Opinion:

• [By Stephan Byrd]

  Shares of Wyndham Hotels & Resorts Inc (NYSE:WH) have been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $71.83.

• [By Stephan Byrd]

  Wyndham Hotels & Resorts (NYSE: WH) and Las Vegas Sands (NYSE:LVS) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership.

• [By Stephan Byrd]

  Wyndham Hotels & Resorts (NYSE:WH) declared a dividend on Monday, May 21st, Fidelity reports. Stockholders of record on Friday, June 15th will be given a dividend of 0.25 per share on Friday, June 29th. The ex-dividend date is Thursday, June 14th.

• [By Joseph Griffin]

  Tower Research Capital LLC TRC acquired a new position in shares of Wyndham Hotels & Resorts Inc (NYSE:WH) in the second quarter, Holdings Channel reports. The institutional investor acquired 2,453 shares of the company’s stock, valued at approximately $145,000.

Top Medical Stocks To Invest In Right Now: Trinity Biotech plc(TRIB)

Advisors' Opinion:

• [By Ethan Ryder]

  Trinity Biotech (NASDAQ: TRIB) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.

• [By Max Byerly]

  Trinity Biotech (NASDAQ: TRIB) is one of 25 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its peers? We will compare Trinity Biotech to related businesses based on the strength of its analyst recommendations, valuation, risk, earnings, dividends, profitability and institutional ownership.